Evidence map›Paper›PMID 38662163›Full record

ArticleDigestive diseases and sciences2024

Development and Validation of a Colorectal Cancer Prediction Model: A Nationwide Cohort-Based Study.

Ofer Isakov, Dan Riesel, Michael Leshchinsky, Galit Shaham, Ben Y Reis, Dan Keret, Zohar Levi, Baruch Brener, Ran Balicer, Noa Dagan and 1 more

Erratum issuedOpen access · hybridAbstract readValidation Study
In one paragraph

Article in Digestive diseases and sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Ofer IsakovInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Dan RieselInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Michael LeshchinskyInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Galit ShahamInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Ben Y ReisDepartment of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Dan KeretGastroenterology and Hepatology Department, Clalit Health Services, Jerusalem, Israel.
Zohar LeviDepartment of Gastroenterology, Beilinson Medical Center, Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Baruch BrenerInstitute of Oncology, Davidoff Cancer Center, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel.
Ran BalicerInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Noa DaganInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel.
Samah HayekInnovation Division, Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel. Samahhayek@tauex.tau.ac.il.
Clalit Health Services · ILHarvard University · USBen-Gurion University of the Negev · ILBoston Children's Hospital · USRabin Medical Center · ILTel Aviv University · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEarly diagnosis of colorectal cancer (CRC) is critical to increasing survival rates. Computerized risk prediction models hold great promise for identifying individuals at high risk for CRC. In order to utilize such models effectively in a population-wide screening setting, development and validation should be based on cohorts that are similar to the target population.

aimEstablish a risk prediction model for CRC diagnosis based on electronic health records (EHR) from subjects eligible for CRC screening.

methodsA retrospective cohort study utilizing the EHR data of Clalit Health Services (CHS). The study includes CHS members aged 50-74 who were eligible for CRC screening from January 2013 to January 2019. The model was trained to predict receiving a CRC diagnosis within 2 years of the index date. Approximately 20,000 EHR demographic and clinical features were considered.

resultsThe study includes 2935 subjects with CRC diagnosis, and 1,133,457 subjects without CRC diagnosis. Incidence values of CRC among subjects in the top 1% risk scores were higher than baseline (2.3% vs 0.3%; lift 8.38; P value < 0.001). Cumulative event probabilities increased with higher model scores. Model-based risk stratification among subjects with a positive FOBT, identified subjects with more than twice the risk for CRC compared to FOBT alone.

conclusionsWe developed an individualized risk prediction model for CRC that can be utilized as a complementary decision support tool for healthcare providers to precisely identify subjects at high risk for CRC and refer them for confirmatory testing.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerAgedCohort StudiesElectronic Health RecordsFemaleHumansIncidenceMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRisk AssessmentRisk FactorsColorectal cancerColorectal cancer screeningMachine learning

Identifiers

PMID38662163
PMCPMC11258054
OpenAlexW4395466384

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.